When supported by Eko’s FDA-cleared AI products, the CORE 500™ flags abnormalities in seconds, including AFib, bradycardia, and tachycardia, to support patient evaluations. As part of the ...

The CORE 500™ Digital Stethoscope is Eko's most advanced stethoscope to date, designed to enhance clinical assessments through patented audio technology with three listening modes (cardiac, pulmonary, ...

PHILADELPHIA, Nov. 25, 2025 /PRNewswire/ -- Impilo, a leading provider in enabling at-home healthcare through software, logistics, and operations support, announced a strategic partnership between its ...

TOKYO, EMERYVILLE, Calif. and COLUMBIA, Md., July 18, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Eko Health Inc. (Co-Founder and CEO: ...

Berkeley, California-based Eko Devices has received FDA 510(k) clearance for its smartphone-enabled stethoscope, called Eko Core as well as the companion smartphone app. Eko Devices, which describes ...

Eko, the maker of devices and platforms for monitoring heart function, has announced the rollout of a second version of its CORE stethoscope that includes noise canceling capabilities and a sound ...

Heart failure with reduced ejection fraction (HFrEF) happens when the heart’s left ventricular ejection fraction (LVEF) is 40% or less, a sign of a weak heart pump. The problem is that this sign of ...

Three UC Berkeley alumni are now among the youngest recipients of Food and Drug Administration approval of a medical device after creating a stethoscope attachment that allows doctors to record and ...

Through future studies, Astellas intends to evaluate if using Z1608 for remote monitoring of key physiological biomarkers associated with heart failure, in addition to providing automated coaching ...